Journal of Cancer Diagnosis
Open Access

HPVScreening: Global Advances, Equity, Challenges

Yuriko Tanaka^*

Nagoya University Hospital, Japan

Received Date: Sep 01, 2025 / Accepted Date: Sep 29, 2025 / Published Date: Sep 29, 2025

Citation: Tanaka Y (2025) HPV Screening: Global Advances, Equity, Challenges. jcd 09: 318.DOI: 10.4172/2476-2253.1000318

Copyright: © 2025 Yuriko Tanaka This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution and reproduction in any medium, provided the original author and source are credited.

To read the full article Peer-reviewed Article PDF

Cervical cancer prevention is evolving with HPV primary screening now standard, offering superior protection and sensitivity
compared to cytology. Global elimination efforts, guided by WHO, emphasize vaccination, screening, and treatment, yet face dispar
ities in low-income countries. Innovations like HPV self-sampling increase participation, while \textit{Artificial Intelligence} (AI)
promises enhanced diagnostic accuracy. HPV vaccination profoundly alters screening protocols by reducing infections, potentially
allowing less frequent screening. Triage for HPV-positive results relies on reflex cytology and emerging molecular biomarkers for
risk stratification. Economic evaluations confirm HPV-based screening’s cost-effectiveness, though social determinants still drive
screening disparities. Molecular diagnostics further refine detection, leading to more targeted follow-up.